| Aug 4 2023 |
FDA Announces Public Meeting to Modernize Recalls |
Keller and Heckman LLP |
| Aug 4 2023 |
Holy Pulmonary Hypertension, Batman: Method of Treatment Not Constrained by Safety and Efficacy |
McDermott Will & Schulte LLP |
| Aug 3 2023 |
OECD Publishes Consensus Document on Environmental Considerations for the Release of Transgenic Plants |
Bergeson & Campbell, P.C. |
| Aug 3 2023 |
Good News, Bad News: Congress Wants to Help the Hemp Industry |
Bradley Arant Boult Cummings LLP |
| Aug 3 2023 |
The Secret to Success: Protecting Your Cannabis Trade Secrets |
Bradley Arant Boult Cummings LLP |
| Aug 2 2023 |
EC Committee Updates Guidance on the Safety Assessment of Nanomaterials in Cosmetics |
Bergeson & Campbell, P.C. |
| Aug 2 2023 |
AAFCO Approves New Model Pet Food and Specialty Pet Food Regulations for Pet Food Packaging |
Keller and Heckman LLP |
| Aug 2 2023 |
FDA Warns “Natural” Birth Control Company: Three Takeaways from the NOV Letter |
Mintz |
| Aug 1 2023 |
BETO Will Host Bioenergy Cybersecurity Workshop on September 11, 2023 |
Bergeson & Campbell, P.C. |
| Aug 1 2023 |
Lawsuit Against Starbucks Dismissed; Sanctions Against Plaintiff’s Attorney Considered |
Keller and Heckman LLP |
| Aug 1 2023 |
Unpacking Averages: Analyzing the Relationship Between MDRs and Recalls |
Epstein Becker & Green, P.C. |
| Aug 1 2023 |
Cancer Moonshot Initiative Adds Precision Surgery Effort |
Foley & Lardner LLP |
| Aug 1 2023 |
EPA Adds Nine PFAS Chemicals to The Toxics Release Inventory Reporting List |
Babst, Calland, Clements & Zomnir, P.C. |
| Aug 1 2023 |
Triaging Health Risks in the Cosmetic World: FDA Says Let’s Start with Tattoo Inks |
Polsinelli PC |
| Aug 1 2023 |
FDA’s LDT Proposed Rule Heads to the White House |
Epstein Becker & Green, P.C. |
| Aug 1 2023 |
Podcast: Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now? – Diagnosing Health Care [Podcast] |
Epstein Becker & Green, P.C. |
| Aug 1 2023 |
Washington State Proposes Sweeping Changes to Key Greenhouse Gas Regulation |
Beveridge & Diamond PC |
| Jul 31 2023 |
UCB, Inc. v. Actavis Laboratories UT, Inc. No. 2021-1924, (Fed. Cir. Apr. 12, 2023) |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 31 2023 |
Proposed Class Action Dismissed Over Lack of Standing |
Keller and Heckman LLP |
| Jul 31 2023 |
The 2024 Proposed Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know |
ArentFox Schiff LLP |
| Jul 31 2023 |
Bipartisan Group of Representatives Calls on EPA to Assess the Risks of PFAS in Fluorinated Containers |
Bergeson & Campbell, P.C. |
| Jul 31 2023 |
APHIS 2022 Impact Report Includes Summary of Biotechnology Activities |
Bergeson & Campbell, P.C. |
| Jul 28 2023 |
Will Mississippi’s List of Qualifying Conditions for Medical Cannabis Soon Be Expanded? |
Bradley Arant Boult Cummings LLP |
| Jul 28 2023 |
Amendment to House Bill Threatens Funding of Organic Standards |
Keller and Heckman LLP |
| Jul 27 2023 |
CMS Proposes Changes to Medicare Provider Enrollment Rules |
Polsinelli PC |
| Jul 27 2023 |
New Medicare Marketing Definition |
Squire Patton Boggs (US) LLP |
| Jul 27 2023 |
CMS Proposes Remedy for 340B-Acquired Drug Payment Policy for CY 2018-2022 |
Foley & Lardner LLP |
| Jul 27 2023 |
FDA Maintains Focus on “Intended Use” for Software-Enabled Medical Devices |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 27 2023 |
FDA Denies Request to Reconsider Petition on Phthalates in Food Packaging |
Keller and Heckman LLP |
| Jul 26 2023 |
Bipartisan Legislation Would Strengthen USDA’s BioPreferred Program |
Bergeson & Campbell, P.C. |
| Jul 26 2023 |
July 2023 EU’s New HBER and Horizontal Guidelines: Main Changes |
Greenberg Traurig, LLP |
| Jul 25 2023 |
First Nonprescription Birth Control Pill Approved for Marketing by FDA: A Milestone for Reproductive Health |
Mintz |
| Jul 25 2023 |
The Netherlands Provides Taste Testing of Cell-Cultivated Meat and Seafood |
Keller and Heckman LLP |
| Jul 25 2023 |
Real Estate Beneficial Ownership Regulatory Alert: Complying with Foreign Ownership Reporting Requirements in US Real Estate |
K&L Gates LLP |
| Jul 25 2023 |
Big Tobacco Bets Big On Cannabis |
Bradley Arant Boult Cummings LLP |
